Adenoid hypertrophy is a common paediatric condition leading to nasal obstruction, mouth breathing, snoring, and recurrent upper respiratory infections, with possible complications such as otitis media and obstructive sleep-disordered breathing.  Homoeopathy offers a holistic, individualised, and non-invasive approach that has shown encouraging results in preliminary studies, but structured clinical evidence remains limited.

This prospective, open-label, single-arm clinical study will be conducted over 12 months at Nehru Homoeopathic Medical College and Hospital, New Delhi. A total of 40 children aged 3–10 years, clinically and radiologically diagnosed with adenoid hypertrophy (A/N ratio >0.5), will be recruited through purposive sampling. Informed consent will be obtained from parents or legal guardians before enrolment. After detailed case taking and analysis, individualised homoeopathic medicines will be prescribed in centesimal or LM potencies, selected on the basis of symptom totality, repertorisation, and standard Materia Medica. Potency and repetition adjusted according to susceptibility and clinical response.

Follow-ups will be conducted monthly for six months, with monitoring of clinical symptoms and NOSE scores. At baseline and at the 6th month, lateral nasopharyngeal X-rays will be performed to calculate the Adenoid–Nasopharynx (A/N) ratio. The primary outcome will be change in A/N ratio and NOSE score from baseline to six months. The secondary outcome will be identification of the most commonly prescribed remedies for adenoid hypertrophy in children.

Data will be documented, compiled, and analyzed statistically. Pharmacovigilance will be maintained throughout the study, with referral to higher centres if adverse events or complications arise. This study seeks to provide structured clinical evidence regarding the effectiveness and safety of individualised homoeopathic treatment as a non-invasive alternative for managing adenoid hypertrophy in children.